ストックスクリーナーアプリを入手
0.00
100.00%
-1.26
前日終値:
$1.26
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$8.60M
収益：
$129.20K
当期純損益:
$-7.44M
株価収益率:
0.00
EPS:
-11.19
ネットキャッシュフロー:
$-8.62M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$19.30
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Company Profile
名前
Sonnet Biotherapeutics Holdings Inc
セクター
電話
609-375-2227
住所
100 OVERLOOK CENTER, PRINCETON, NJ
Compare SONN vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SONN
Sonnet Biotherapeutics Holdings Inc
|
0.00 | 8.60M | 129.20K | -7.44M | -8.62M | -11.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Sonnet Biotherapeutics Holdings Inc (SONN) 最新ニュース
Aug Reactions: Does Sonnet BioTherapeutics Holdings Inc align with a passive investing strategy2025 Buyback Activity & Daily Entry Point Alerts - baoquankhu1.vn
Aug Outlook: Is Sonnet BioTherapeutics Holdings Inc stock a good dividend stock2025 Risk Factors & Fast Gain Swing Alerts - baoquankhu1.vn
Aug Ideas: What makes AIFU stock attractive todayMarket Activity Summary & Weekly High Potential Stock Alerts - baoquankhu1.vn
Can Sonnet BioTherapeutics Holdings Inc. stock continue upward trendJuly 2025 Momentum & Free Technical Pattern Based Buy Signals - mfd.ru
Why Sonnet BioTherapeutics Holdings Inc. stock attracts global investors2025 Dividend Review & Low Risk Investment Opportunities - mfd.ru
Why Sonnet BioTherapeutics Holdings Inc. stock is considered a top pickJuly 2025 Update & Advanced Swing Trade Entry Alerts - mfd.ru
Does Sonnet BioTherapeutics Holdings Inc. align with a passive investing strategy2025 Macro Impact & Fast Moving Trade Plans - mfd.ru
What’s the outlook for Sonnet BioTherapeutics Holdings Inc.’s sectorJobs Report & Technical Analysis for Trade Confirmation - mfd.ru
Hyperliquid Strategies posts $318 million net loss on $262 million unrealized HYPE losses - The Block
What’s the MACD signal for Sonnet BioTherapeutics Holdings Inc.Portfolio Risk Report & Expert Verified Stock Movement Alerts - mfd.ru
Published on: 2026-02-08 12:03:59 - baoquankhu1.vn
What is the next catalyst for Sonnet BioTherapeutics Holdings IncMarket Trend Report & Community Consensus Picks - baoquankhu1.vn
Chart Watch: Whats the outlook for Sonnet BioTherapeutics Holdings Incs sector2025 Buyback Activity & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Sonnet BioTherapeutics Adjourns Meeting for Business Combination - MSN
Aug Decliners: Should I invest in Sonnet BioTherapeutics Holdings Inc before earningsJuly 2025 Breakouts & Low Drawdown Investment Strategies - baoquankhu1.vn
Quarterly Trades: Whats the outlook for Sonnet BioTherapeutics Holdings Incs sectorStop Loss & Reliable Breakout Forecasts - baoquankhu1.vn
Bear Alert: What is the target price for Sonnet BioTherapeutics Holdings Inc stock2025 Earnings Surprises & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Risk Recap: Can Sonnet BioTherapeutics Holdings Inc. stock maintain growth trajectoryInflation Watch & Short-Term High Return Strategies - Bộ Nội Vụ
Growth Value: Should I average down on Sonnet BioTherapeutics Holdings Inc stock2025 Price Targets & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Published on: 2026-01-13 09:37:35 - baoquankhu1.vn
Published on: 2026-01-12 20:21:52 - baoquankhu1.vn
Is Sonnet BioTherapeutics Holdings Inc. stock a defensive play in 2025Earnings Recap Report & Consistent Profit Trade Alerts - Улправда
Should I hold or sell Sonnet BioTherapeutics Holdings Inc. stock in 2025Quarterly Trade Review & Daily Profit Maximizing Trade Tips - Улправда
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for income investorsGold Moves & Free Expert Verified Stock Movement Alerts - Улправда
Is Sonnet BioTherapeutics Holdings Inc. stock vulnerable to regulatory risksChart Signals & Free Long-Term Investment Growth Plans - Улправда
Why Sonnet BioTherapeutics Holdings Inc. stock is a must watch in 2025Value Traps to Avoid & Build Wealth With Strategy - ulpravda.ru
Can Sonnet BioTherapeutics Holdings Inc. stock maintain growth trajectoryMarket Insider Reports & Budget Friendly Portfolio - Улправда
Sonnet BioTherapeutics Stock Jumps 82% After Deal With Rorschach I: Retail Stays Exuberant - MSN
Ideas Watch: Should I hold or sell Sonnet BioTherapeutics Holdings Inc stock in 2025Weekly Profit Summary & Community Trade Idea Sharing Platform - moha.gov.vn
Breakout Move: Will Sonnet BioTherapeutics Holdings Inc stock benefit from automationEarnings Growth Summary & Verified Momentum Stock Ideas - moha.gov.vn
Head to Head Comparison: Sonnet BioTherapeutics (NASDAQ:SONN) & BioXcel Therapeutics (NASDAQ:BTAI) - Defense World
Will Sonnet BioTherapeutics Holdings Inc. stock deliver better than expected guidanceBear Alert & Free Verified High Yield Trade Plans - Улправда
Will Sonnet BioTherapeutics Holdings Inc. stock benefit from automationJuly 2025 Earnings & AI Optimized Trading Strategy Guides - DonanımHaber
Will Sonnet BioTherapeutics Holdings Inc. stock maintain growth storyTrade Signal Summary & Real-Time Market Sentiment Reports - DonanımHaber
Sonnet BioTherapeutics (NASDAQ: SONN) updates FHAB-based oncology pipeline - Stock Titan
[EFFECT] Sonnet BioTherapeutics Holdings, Inc. SEC Filing - Stock Titan
Sonnet BioTherapeutics Holdings: Net loss of $16.0M on $1.0M revenue, with urgent need for new funding to sustain operations - TradingView — Track All Markets
Sonnet BioTherapeutics (NASDAQ:SONN) Shares Down 67.3% – Here’s Why - Defense World
What analysts say about Sonnet BioTherapeutics Holdings Inc stockMarket Timing Techniques & Low Cost Wealth Building - earlytimes.in
Lowenstein Represents Sonnet BioTherapeutics In Closing Of Business Combination With Hyperliquid Strategies - Mondaq
Officer Kenney Acquires 233,374 Of Sonnet BioTherapeutics Holdings Inc [SONN] - TradingView
Hyperliquid Strategies Moves $411M in HYPE to Hypercore - Live Bitcoin News
Will HYPE extend rally as Hyperliquid Strategies Inc. begins staking? - FXStreet
Sonnet BioTherapeutics Stockholders Greenlight Hyperliquid Strategies Merger Deal - Blockonomi
Sonnet’s $1B Hype Treasury Signals Ambitious Digital Asset Expansion After Merger Approval - Crypto Economy
Sonnet BioTherapeutics Merges with Hyperliquid Strategies - TipRanks
Biotech Trio Gets Hammered On Heavy Trading - Finimize
Is Sonnet BioTherapeutics Holdings Inc. stock attractive for hedge fundsWeekly Trend Summary & Real-Time Buy Zone Alerts - Newser
Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock: Merges Into Hyperliquid Era with Nasdaq Debut as PURR - parameter.io
Sonnet BioTherapeutics Enters a New Frontier with a $1 Billion HYPE Digital Asset Treasury - OneSafe
Sonnet BioTherapeutics shareholders approve proposed business merger with Hyperliquid Strategies Inc. - Bitget
Sonnet Biotherapeutics Holdings Inc (SONN) 財務データ
収益
当期純利益
現金流量
EPS
0.48%
1.21%
大文字化:
|
ボリューム (24 時間):